CLARENTIS Ultra-Lyte® added to N List

Ultra-Lyte® was added by the  US EPA to the N list, so it can be used against SARS-CoV-2 (Covid-19), after Ultra-Lyte® had demonstrated effectiveness against viruses similar to Norovirus (Feline Calicivirus as a surrogate) on hard, non-porous surfaces.

Ultra-Lyte was also approved by Health Canada for use against Sars-CoV-2, and Norovirus, after it had demonstrated effectiveness against both the Human Coronavirus (with Human Corona Virus Strain 229E as a surrogate) and Norovirus ( with Feline Calicivirus as a surrogate).

CLARENTIS added to Journal of Hospital Infection (3 of 3)

Journal of Hospital Infection*, 94, 2 (October) 2016, page 169-174

Elimination of biofilm and microbial contamination reservoirs in hospital washbasin U-bends by automated cleaning and disinfection with electrochemically activated solutions**

J.S. Swan a, E.C. Deasy b, M.A. Boyle b, R.J. Russell c, M.J. O’Donnell b, D.C. Coleman b, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland Department of Microbiology, University of Dublin, Trinity College Dublin, Dublin 2, Ireland

**Acknowledgements: We thank  Qlean Enterprises, LLC, for providing, installing, and commissioning the Clarentis Ultra-Lyte Mini-UL-75a ECA generator used in this study.

CLARENTIS added to Journal of Hospital Infection (2 of 3)

Journal of Hospital Infection*, 100,(2018) e 98 e-104 , continuation of 94, 2, 2016, page 169-174

Minimizing Microbial Contamination Risk simultaneously from multiple hospital washbasins by automated cleaning of U-bends with electrochemically activated solutions

E.C. Deasy , E.M. Moloney, M.A. Boyle , J.S. Swan , D.A. Geoghegan, G.I. Brennan, T.E. Fleming, M.J. O’Donnell,  D.C. Coleman

Anolyte and catholyte solutions were produced by electrochemical activation of an NaCl solution using a Clarentis UL-75a ECA generator. The generator was configured to produce anolyte measured at 800 parts per million (ppm) free available chlorine (FAC)  at pH 7, having an oxidation reduction potential (ORP) of +880 mV  and consisting of approximately 632 ppm of hypochlorous acid (79%) and 162 ppm of  OCl¯ (20.2%). Catholyte is an amphoteric surfactant with a surface tension of 63nM force and was produced  at pH 12.5 and ORP of approximately -1000 mV ORP, consisting of approximately 400 ppm of NaOH. Freshly generated anolyte was used undiluted. Freshly generated catholyte was diluted 1:5 with mains water with a temperature after dilution of approximately 33° C.

Conclusion: Simultaneous automated treatment of hospital washbasin U-bends with ECA consistently minimizes bacterial contamination infection and thus the associated risk of infection.

CLARENTIS added to Journal of Hospital Infection (1 of 3)

Journal of Hospital Infection, 104 (2020) 484-491, E.M. Moloney et al.

Whole-genome sequencing identifies highly related Pseudomonas aeruginosa strains in multiple washbasin U-bends at several locations in one hospital: evidence for trafficking of potential wastewater pipes.

E.M. Moloney, E.C. Deasy, J.S. Swan, G. I. Brennan, M.J. O’Donnell, D.C. Coleman

Microbiology Research Unit, Division of Oral Biosciences, Dublin Dental University Hospital, University of  Dublin, Trinity College, Dublin, Ireland

b Facilities Department, Dublin Dental University Hospital, Dublin, Ireland

c National MRSA Reference Laboratory, St. James’s Hospital, Dublin, Ireland

CLARENTIS® Intellectual Property Update

September 23, 2016. CLARENTIS received notice from the Intellectual Property Office of Singapore that its patent application No. 201201040-1, Van Kalken/Waldner, was issued on September 2, 2016, as “System and Method for preparation of antimicrobial Solution”.

With equipment installed in Africa and Europe, CLARENTIS is expanding its foreign operations to the Middle East, Hong Kong, Indonesia, Malaysia and Thailand.